{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T18:14:34Z","timestamp":1770488074742,"version":"3.49.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Priapism is a urologic emergency with a tendency to recur in some patients. The frequency of, time to, and risk factors for priapism recurrence have not been well characterized.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To identify predictors of priapism readmission.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We used the New York Statewide Planning and Research Cooperative System database to identify patients presenting to emergency departments with priapism from 2005 through 2014. Patients were tracked up to 12 months after initial presentation. Proportional hazards regression was used to identify risk factors for priapism readmission.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Readmissions for priapism.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The analytic cohort included 3,372 men with a diagnosis of priapism. The average age at first presentation was 39 \u00b1 18 years and 40% were black. Within 1 year, 24% of patients were readmitted for recurrent priapism, 68% of whom were readmitted within 60 days. On multivariate analysis, sickle cell disease (hazard ratio [HR] = 2.5, 95% CI = 2.0\u20133.0), drug abuse or psychiatric disease (HR = 1.9, 95% CI = 1.6\u20132.2), erectile dysfunction history (HR = 1.9, 95% CI = 1.5\u20132.3), other than commercial medical insurance (HR = 1.2, 95% CI = 1.0\u20131.4), and inpatient admission for initial priapism event (HR = 0.5, 95% CI = 0.4\u20130.6) were significant risk factors for readmission.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Nearly one fourth of patients with priapism were readmitted for recurrent priapism within 1 year of initial presentation. Most readmissions were within 60 days. Future research should focus on strategies to decrease recurrences in high-risk patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1016\/j.jsxm.2016.07.009","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T05:42:53Z","timestamp":1470289373000},"page":"1555-1561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Risk Factors for Priapism Readmission"],"prefix":"10.1093","volume":"13","author":[{"given":"Wilson","family":"Sui","sequence":"first","affiliation":[{"name":"Department of Urology \u00a0 , New York, NY , USA"},{"name":"Columbia University Medical Center \u00a0 , New York, NY , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ifeanyi C.","family":"Onyeji","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , New York, NY , USA"},{"name":"Columbia University Medical Center \u00a0 , New York, NY , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxwell B.","family":"James","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , New York, NY , USA"},{"name":"Columbia University Medical Center \u00a0 , New York, NY , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Stahl","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , New York, NY , USA"},{"name":"Columbia University Medical Center \u00a0 , New York, NY , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arindam","family":"RoyChoudhury","sequence":"additional","affiliation":[{"name":"Department of Biostatistics \u00a0 \u00a0 , New York, NY , USA"},{"name":"Mailman School of Public Health \u00a0 \u00a0 , New York, NY , USA"},{"name":"Columbia University \u00a0 \u00a0 , New York, NY , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , New York, NY , USA"},{"name":"Columbia University Medical Center \u00a0 , New York, NY , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,10,1]]},"reference":[{"key":"2024032602350865800_bib1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2013.11.008","article-title":"European Association of Urology guidelines on priapism","volume":"65","author":"Salonia","year":"2014","journal-title":"Eur Urol"},{"key":"2024032602350865800_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0140-6736(02)86187-6","article-title":"Clinical contributions from private practice: case of continued priapism","volume":"46","author":"Tripe","year":"1845","journal-title":"Lancet"},{"key":"2024032602350865800_bib3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/00000658-191412000-00004","article-title":"Priapism: report of cases and a clinical study of the literature with reference to its pathogenesis and surgical treatment","volume":"60","author":"Hinman","year":"1914","journal-title":"Ann Surg"},{"key":"2024032602350865800_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/00365599509180545","article-title":"Priapism, its incidence and seasonal distribution in Finland","volume":"29","author":"Kulmala","year":"1995","journal-title":"Scand J Urol Nephrol"},{"key":"2024032602350865800_bib5","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0090-4295(01)00941-4","article-title":"Incidence of priapism in the general population","volume":"57","author":"Eland","year":"2001","journal-title":"Urology"},{"key":"2024032602350865800_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.ijir.3901018","article-title":"The incidence and management of priapism in Western Australia: a 16 year audit","volume":"15","author":"Earle","year":"2003","journal-title":"Int J Impot Res"},{"key":"2024032602350865800_bib7","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.juro.2013.03.118","article-title":"Incidence of priapism in emergency departments in the United States","volume":"190","author":"Roghmann","year":"2013","journal-title":"J Urol"},{"key":"2024032602350865800_bib8","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/jsm.12251","article-title":"Nationwide emergency department visits for priapism in the United States","volume":"10","author":"Stein","year":"2013","journal-title":"J Sex Med"},{"key":"2024032602350865800_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/ncpuro0277","article-title":"Therapy insight: priapism associated with hematologic dyscrasias","volume":"2","author":"Burnett","year":"2005","journal-title":"Nat Clin Pract Urol"},{"key":"2024032602350865800_bib10","volume-title":"Campbell-Walsh urology","author":"Wein","year":"2012","edition":"10th ed."},{"key":"2024032602350865800_bib11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0022-5347(17)58497-9","article-title":"Priapism: evolution of management in 48 patients in a 22-year series","volume":"117","author":"Nelson","year":"1977","journal-title":"J Urol"},{"key":"2024032602350865800_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.amjsurg.2010.03.017","article-title":"Priapism in the United States: the changing role of sickle cell disease","volume":"201","author":"Chrouser","year":"2011","journal-title":"Am J Surg"},{"key":"2024032602350865800_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-5347(17)38248-4","article-title":"Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae","volume":"145","author":"Fowler","year":"1991","journal-title":"J Urol"},{"key":"2024032602350865800_bib14","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1046\/j.1464-410X.2002.03022.x","article-title":"Priapism in sickle-cell disease; incidence, risk factors and complications\u2014an international multicentre study","volume":"90","author":"Adeyoju","year":"2002","journal-title":"BJU Int"},{"key":"2024032602350865800_bib15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/jsm.12816","article-title":"Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors","volume":"12","author":"Anele","year":"2015","journal-title":"J Sex Med"},{"key":"2024032602350865800_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"2024032602350865800_bib17","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1046\/j.1365-2141.2002.03691.x","article-title":"Etilefrine for the prevention of priapism in adult sickle cell disease","volume":"118","author":"Okpala","year":"2002","journal-title":"Br J Haematol"},{"key":"2024032602350865800_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2164\/jandrol.110.010934","article-title":"A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: report of an international randomized control trial\u2014the Priapism in Sickle Cell Study","volume":"32","author":"Olujohungbe","year":"2011","journal-title":"J Androl"},{"key":"2024032602350865800_bib19","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1182\/blood-2014-09-551887","article-title":"How I treat priapism","volume":"125","author":"Anele","year":"2015","journal-title":"Blood"},{"key":"2024032602350865800_bib20","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0407183102","article-title":"Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism","volume":"102","author":"Champion","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024032602350865800_bib21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjmed.2014.03.019","article-title":"Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease","volume":"127","author":"Burnett","year":"2014","journal-title":"Am J Med"},{"key":"2024032602350865800_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0090-4295(01)01492-3","article-title":"Antiandrogens in the treatment of priapism","volume":"59","author":"Dahm","year":"2002","journal-title":"Urology"},{"key":"2024032602350865800_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jsm.12359","article-title":"Prevention of recurrent ischemic priapism with ketoconazole: evolution of a treatment protocol and patient outcomes","volume":"11","author":"Hoeh","year":"2014","journal-title":"J Sex Med"},{"key":"2024032602350865800_bib24","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s11255-014-0737-7","article-title":"Hydroxyurea therapy for priapism prevention and erectile function recovery in sickle cell disease: a case report and review of the literature","volume":"46","author":"Anele","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"2024032602350865800_bib25","first-page":"193694","article-title":"Priapism, ecstasy, and marijuana: is there a connection?","volume-title":"Adv Urol","author":"Tran","year":"2008"},{"key":"2024032602350865800_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/YIC.0b013e3282f1c1ef","article-title":"Priapism associated with atypical antipsychotic medications: a review","volume":"23","author":"Sood","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"2024032602350865800_bib27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1742-1241.2009.02254.x","article-title":"Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database","volume":"64","author":"Giuliano","year":"2010","journal-title":"Int J Clin Pract"},{"key":"2024032602350865800_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/jsm.12023","article-title":"SOP conservative (medical and mechanical) treatment of erectile dysfunction","volume":"10","author":"Porst","year":"2013","journal-title":"J Sex Med"},{"key":"2024032602350865800_bib29","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1111\/j.1464-410X.2012.11080.x","article-title":"A review of outcomes of an intracavernosal injection therapy programme","volume":"110","author":"Coombs","year":"2012","journal-title":"BJU Int"},{"key":"2024032602350865800_bib30","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jclinepi.2006.01.004","article-title":"International classification of diseases and current procedural terminology codes underestimated thrombolytic use for ischemic stroke","volume":"59","author":"Qureshi","year":"2006","journal-title":"J Clin Epidemiol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609516303265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609516303265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/13\/10\/1555\/48194674\/jsm_13_10_1555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/13\/10\/1555\/48194674\/jsm_13_10_1555.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T02:53:39Z","timestamp":1711421619000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/13\/10\/1555\/6940485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,1]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,1]]},"published-print":{"date-parts":[[2016,10,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2016.07.009","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,10]]},"published":{"date-parts":[[2016,10,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Priapism Readmission","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2016.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine.","name":"copyright","label":"Copyright"}]}}